“Pharmacogenetic effects of angiotensin-converting enzyme inhibitors over age-related urea and creatinine variations in patients with dementia due to Alzheimer disease”, Colomb Med, vol. 47, no. 2, pp. 76–80, Jun. 2016, doi: 10.25100/cm.v47i2.2188.